About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The goal of the Shock, Organic Dysfunction and Resuscitation Research Group (SODIR) is comprehensive, innovative research into the areas of shock, acute respiratory failure, acute kidney failure, organic dysfunction, resuscitation and critical patient monitoring. In addition, the research group has a special interest in applying artificial intelligence as an instrument to find innovative solutions for critical patients.
PMID: 34996993 Journal: Scientific Reports Year: 2022 Reference: Sci Rep. 2022 Jan 7;12(1):28. doi: 10.1038/s41598-021-03970-w. Impact factor: Publication type: Paper in international publication Authors: Alvarez Lerma, Francisco; Catalan Gonzalez, Mercedes; Escriba Barcena, Almudena; Jaen Herreros, Felisa; Montejo Gonzalez, Juan Carlos; Nuvials Casals, Xavier; Palomar Martinez, Mercedes; Renes Carreno, Emilio et al. DOI: 10.1038/s41598-021-03970-w
PMID: 36699492 Journal: Frontiers in Psychiatry Year: 2022 Reference: Front Psychiatry. 2023 Jan 9;13:1015489. doi: 10.3389/fpsyt.2022.1015489. eCollection 2022. Impact factor: Publication type: Paper in international publication Authors: Aluja, Anton; Calvo, Natalia; Ferrer, Marc; Ferrer, Marc; Gallart, Salvador; Garriz, Miguel; Gutierrez, Fernando; Gutierrez-Zotes, Alfonso; Pascual, Juan Carlos; Peri, Josep M et al. DOI: 10.3389/fpsyt.2022.1015489
PMID: 37386575 Journal: Year: 2022 Reference: J Anesth Analg Crit Care. 2022 Apr 4;2(1):15. doi: 10.1186/s44158-022-00043-w. Impact factor: Publication type: Paper in international publication Authors: Chiscano-Camon, Luis; Ferrer, Ricard; Plata-Menchaca, Erika P; Ruiz-Rodriguez, Juan Carlos; Ruiz-Sanmartin, Adolf et al. DOI: 10.1186/s44158-022-00043-w
PMID: 34903475 Journal: Medicina Intensiva Year: 2022 Reference: Med Intensiva (Engl Ed). 2022 Feb;46(2):81-89. doi: 10.1016/j.medine.2021.11.019. Epub 2021 Dec 10. Impact factor: 2.491 Publication type: Paper in international publication Authors: Estella, A; Vidal-Cortes, P; Diaz Santos, E; Aguilar Alonso, E; Amezaga Menendez, R; Ballesteros, M A; Bodi, M A; Bordeje Laguna, M L; Garnacho Montero, J; Garcia Sanchez, M et al. DOI: 10.1016/j.medine.2021.11.019
PMID: 33805755 Journal: Antibiotics-Basel Year: 2021 Reference: Antibiotics (Basel). 2021 Mar 13;10(3). pii: antibiotics10030299. doi: 10.3390/antibiotics10030299. Impact factor: Publication type: Paper in international publication Authors: Agodi, Antonella; Biesiada, Grazyna; Brzozowski, Bartosz; Czepiel, Jacek; Deptula, Aleksander; Enoch, David A; Fedewicz, Marcin; Filipczak-Bryniarska, Iwona; Garlicki, Aleksander; Goldman-Mazur, Sarah et al. DOI: 10.3390/antibiotics10030299
PMID: 33810263 Journal: Antibiotics-Basel Year: 2021 Reference: Antibiotics (Basel). 2021 Mar 26;10(4). pii: antibiotics10040350. doi: 10.3390/antibiotics10040350. Impact factor: Publication type: Paper in international publication Authors: Bodi, Maria; Carbonell, Raquel; Diaz, Emili; Estella, Angel; Gomez, Josep; Gomez-Bertomeu, Frederic; Guardiola, Juan Jose; Jimenez Herrera, Maria; Martin-Loeches, Ignacio; Moreno, Gerard et al. DOI: 10.3390/antibiotics10040350
PMID: 33813139 Journal: EBioMedicine Year: 2021 Reference: EBioMedicine. 2021 Apr;66:103291. doi: 10.1016/j.ebiom.2021.103291. Epub 2021 Apr 1. Impact factor: Publication type: Review in international publication Authors: Brunkhorst, Frank M; Cajander, Sara; Cavaillon, Jean-Marc; Ferrer, Ricard; Flohe, Stefanie B; Garcia-Salido, Alberto; Giamarellos-Bourboulis, Evangelos J; Girardis, Massimo; Kox, Matthijs; Lachmann, Gunnar et al. DOI: 10.1016/j.ebiom.2021.103291
PMID: 32703653 Journal: Medicina Intensiva Year: 2021 Reference: Med Intensiva. 2021 Apr;45(3):164-174. doi: 10.1016/j.medin.2020.06.007. Epub 2020 Jul 20. Impact factor: Publication type: Paper in national publication Authors: Chico Fernandez, M; Ferrer Roca, R; Garcia Acuna, J M; Lesmes Serrano, A; Lopez de Sa, E; Roldan Ramirez, J; Sanchez Salado, J C et al. DOI: 10.1016/j.medin.2020.06.007
PMID: 32702395 Journal: RESUSCITATION Year: 2020 Reference: Resuscitation. 2020 Oct;155:1-2. doi: 10.1016/j.resuscitation.2020.07.008. Epub 2020 Jul 21. Impact factor: 4.215 Publication type: Letter or abstract Authors: Ruiz-Rodriguez, Juan Carlos, Camon, Luis Chiscano, Ruiz, Daniel, Lacasa, Judit Sacanell, Serra, Eduard Argudo, Casals, Francesc Xavier Nuvials, Ferrer, Ricard et al. DOI: 10.1016/j.resuscitation.2020.07.008
PMID: 32697495 Journal: CRITICAL CARE MEDICINE Year: 2020 Reference: Crit Care Med. 2020 Aug;48(8):1217-1232. doi: 10.1097/CCM.0000000000004408. Impact factor: 7.414 Publication type: Paper in international publication Authors: Deutschman, Clifford S, Hellman, Judith, Ferrer Roca, Ricard, De Backer, Daniel, Coopersmith, Craig M et al. DOI: 10.1097/CCM.0000000000004408
PMID: 32676795 Journal: Intensive care medicine experimental Year: 2020 Reference: Intensive Care Med Exp. 2020 Jul 17;8(1):31. doi: 10.1186/s40635-020-00312-4. Impact factor: 0 Publication type: Paper in international publication Authors: Deutschman, Clifford S, Hellman, Judith, Roca, Ricard Ferrer, De Backer, Daniel, Coopersmith, Craig M, Coopersmith, Craig M, De Backer, Daniel, Antonelli, Massimo, Deutschman, Clifford S, Evans, Laura et al. DOI: 10.1186/s40635-020-00312-4
PMID: 32627615 Journal: Hospital practice (1995) Year: 2020 Reference: Hosp Pract (1995). 2020 Jul 20:1-11. doi: 10.1080/21548331.2020.1791541. Impact factor: 0 Publication type: Review in international publication Authors: Plata, Erika, Ferrer, Ricard, Ruiz Rodriguez, Juan Carlos, Morais, Rui, Povoa, Pedro et al. DOI: 10.1080/21548331.2020.1791541
On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.
Hybrids VITA, developed together with Medical Simulator, reproduces different clinical scenarios for training on how to prevent, diagnose and treat possible complications of ECMO, which is a very complex technique.
Extracorporeal Cardiopulmonary Resuscitation (ECPR) offers therapeutic options for patients in whom conventional cardiopulmonary resuscitation techniques fail to restore the heartbeat.
